Skip to content
10-Q

Quarterly Report

AIFARM, LTD.

0001654954-19-013029

← back to feed
Filed
Nov 14, 2019 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2019 · Nov 14, 2019 56.2M sh
Stock Issued Q3 2019 · Sep 30, 2019 5.63M sh
Operating Cash Flow Q3 2019 · Sep 30, 2019 −$419.84K
Operating Cash Flow Q3 2019 · Sep 30, 2018 −$51.81K
Stockholders Equity Q3 2019 · Sep 30, 2019 −$1.82M
Stockholders Equity Q3 2019 · Dec 31, 2018 −$1.95M
Total Liabilities Q3 2019 · Sep 30, 2019 $3.54M
Total Liabilities Q3 2019 · Dec 31, 2018 $3.59M
Total Assets Q3 2019 · Sep 30, 2019 $169.19K
Total Assets Q3 2019 · Dec 31, 2018 $97.12K
Sga Expense Q3 2019 · Sep 30, 2019 $218.84K
Sga Expense Q3 2019 · Sep 30, 2019 $430.65K
Sga Expense restated Q3 2019 · Sep 30, 2018 $7.24K
Sga Expense restated Q3 2019 · Sep 30, 2018 $51.81K
Net Income Q3 2019 · Sep 30, 2019 −$218.84K
Net Income Q3 2019 · Sep 30, 2019 −$430.65K
Net Income Q3 2019 · Sep 30, 2018 −$7.24K
Net Income Q3 2019 · Sep 30, 2018 −$51.81K